Ballard Karen S, Thurston Brian C, Sennett Michael D, Tedjarati Sean S
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, East Carolina University Brody School of Medicine, 600 Moye Boulevard, 2S-12, Brody Medical Building, Greenville, NC 27834, USA.
J Reprod Med. 2009 Aug;54(8):517-9.
A malignant Brenner tumor is a rare form of invasive epithelial ovarian cancer and is extremely uncommon in women > 65 years of age. We present a case of an invasive Brenner tumor of the ovary in a woman greater than age 70.
A 77-year-old woman presented with a rare, invasive Brenner tumor of the ovary. She was referred for evaluation of a complex pelvic mass and elevated serum CA-125. Treatment included complete surgical resection and staging procedure. Pathology revealed a malignant Brenner tumor. Immunohistochemical staining with cytokeratin 7 was positive, with cytokeratin 20 was negative, and was positive for uroplakin III and thrombomodulin.
The histologic appearance of malignant Brenner tumor is similar to that of transitional cell cancer of the ovary and transitional epithelium of the urinary bladder. Immunohistochemical staining of malignant Brenner tumor often demonstrates positivity for uroplakin III, thrombomodulin and cytokeratin 7 and negativity to cytokeratin 20. The mainstay of treatment is surgical resection, but the exact regimen and benefit of adjuvant therapy remain unknown.
恶性勃勒纳瘤是侵袭性上皮性卵巢癌的一种罕见形式,在65岁以上女性中极为罕见。我们报告一例70岁以上女性的侵袭性卵巢勃勒纳瘤病例。
一名77岁女性患有罕见的侵袭性卵巢勃勒纳瘤。她因复杂盆腔肿块和血清CA-125升高而前来评估。治疗包括完整的手术切除和分期手术。病理显示为恶性勃勒纳瘤。细胞角蛋白7免疫组化染色阳性,细胞角蛋白20阴性,uroplakin III和血栓调节蛋白阳性。
恶性勃勒纳瘤的组织学表现与卵巢移行细胞癌及膀胱移行上皮相似。恶性勃勒纳瘤的免疫组化染色通常显示uroplakin III、血栓调节蛋白和细胞角蛋白7阳性,细胞角蛋白20阴性。治疗的主要方法是手术切除,但辅助治疗的确切方案和益处仍不明确。